Donna is a pediatric cancer research advocate. Her son Erik battled neuroblastoma and suffered a late relapse, diagnosed in 1991 at age 6 and died in 2010 at age 24. She has been involved in the pediatric cancer community for decades. She serves on several councils including the NCI Pediatric Central Review Board, NCI Pediatric and Adolescent Solid Tumor Steering Committee, FDA Patient Representative, NANT Parent Advisory Council, prior founding Board of Directors of Coalition Against Childho...
All content for An Unexpected Fight: A Pediatric Cancer podcast is the property of An Unexpected Fight and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Donna is a pediatric cancer research advocate. Her son Erik battled neuroblastoma and suffered a late relapse, diagnosed in 1991 at age 6 and died in 2010 at age 24. She has been involved in the pediatric cancer community for decades. She serves on several councils including the NCI Pediatric Central Review Board, NCI Pediatric and Adolescent Solid Tumor Steering Committee, FDA Patient Representative, NANT Parent Advisory Council, prior founding Board of Directors of Coalition Against Childho...
Dr. Schultz - Principal Investigator of the International PPB/DICER1 Registry
An Unexpected Fight: A Pediatric Cancer podcast
46 minutes
4 months ago
Dr. Schultz - Principal Investigator of the International PPB/DICER1 Registry
As Principal Investigator of the International PPB/DICER1 Registry and founder of the International OTST Registry, Dr. Schultz is at the forefront of developing novel treatments for some of the rarest and most aggressive pediatric cancers. 🎧 In this episode, we dive deep into: ✨ The importance of registries in rare cancer research ✨ What families facing a DICER1 diagnosis need to know ✨ Her inspiring journey in pediatric oncology ✨ Why collaboration is key to hope and ...
An Unexpected Fight: A Pediatric Cancer podcast
Donna is a pediatric cancer research advocate. Her son Erik battled neuroblastoma and suffered a late relapse, diagnosed in 1991 at age 6 and died in 2010 at age 24. She has been involved in the pediatric cancer community for decades. She serves on several councils including the NCI Pediatric Central Review Board, NCI Pediatric and Adolescent Solid Tumor Steering Committee, FDA Patient Representative, NANT Parent Advisory Council, prior founding Board of Directors of Coalition Against Childho...
